Evogene Ltd EVGN 深 滬
等待開盤 06-25 09:30:00 美东时间
0.4392
-0.052
-10.55%
華盛通- 最 高0.4717
- 今 開0.4402
- 成交量 3433.64万股
- 最 低 0.3905
- 昨 收 0.491
- 總市值 531.63万
- 52周最高 1.50
- 市盈率 靜 --
- 換手率 283.67%
- 52周最低 0.3905
- 委 比 -50.00%
- 總股本 1210.45万
- 歷史最高 203.90
- 量 比 182.46
- 振 幅 16.54%
- 歷史最低 0.3905
- 每 手 1
- 風險率 0.24%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Evogene Sets Up $2.9 Million At-the-Market Share Offering With A.G.P.
Evogene ( ($EVGN) ) has shared an announcement. On June 11, 2026, Evogene Ltd. ...
06-12 04:28
Full Transcript: Evogene Q1 2026 Earnings Call
Evogene (NASDAQ:EVGN) reported first-quarter financial results on Wednesday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/ap...
06-11 18:51
Evogene Reports Early Results for Cancer Therapy Study, Experimental Treatment Meets Safety Goal in First Human Trial
Evogene Ltd. ("Evogene") (NASDAQ:EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing in generative design of small molecules for the pharmaceutical and agricultural industries, today announced
06-02 19:06
Evogene Files Secondary Offering Of 2,446,707 Shares By Selling Shareholder
- SEC filing
05-20 20:53
Earnings Scheduled For May 20, 2026
Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is likely to re...
05-20 19:11
Evogene misses Q1 estimates
Evogene press release (EVGN): Q1 GAAP EPS of -$0.60 misses by $0.33. Revenue of $0.3M (-100.0% Y/Y) misses by $0.05M. As of March 31, 2026, Evogene held consolidated cash, cash equivalents, and short...
05-20 19:06
Evogene Q1 EPS $(0.60) Misses $(0.27) Estimate, Sales $334.000K Miss $350.000K Estimate
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.27) by 122.22 percent. This is a 57.89 percent decrease over losses of $(0.38) per share from the
05-20 19:01
Evogene to Present at the 24th Schrödinger European User Group Meeting
Conference will be held in Munich, Germany - May 19-21, 2026 REHOVOT, Israel, May 12, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational che...
05-12 20:00
Evogene receives Nasdaq notification
Evogene Ltd. (NASDAQ: EVGN) said on Thursday it had received a notice from the Nasdaq indicating that it had fallen out of compliance with Nasdaq Rule 5550(a)(2) after its shares had closed below $1.0...
04-03 04:09
Evogene Receives Nasdaq Noncompliance Notification, Gets Time Through Sept. 28 To Regain Compliance
Evogene Ltd. (NASDAQ:EVGN)(TASE: EVGN) (the "Company", "Evogene"), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural
04-03 04:02
